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ABSTRACT  The response of the isolated amphibian urinary bladder to thirty- 
four structural  analogs  of arginine  vasotocin was  determined  in  an  effort to 
define the physiological significance of specific structural groups on the hormone 
molecule.  All but one of the  analogs  tested possessed  full intrinsic  activity in 
this system but varied greatly in their affinity for the receptor site. An analysis 
of the effect of changes in hydrogen ion concentration upon the response of the 
bladder  to  oxytocin was  performed  in  order  to  determine  the  number  and 
nature of the ionizable groups involved in hormone receptor interaction.  Two 
ionizable groups with apparent pK's of 7.1 and 7.75 were found to be important 
in determining  the magnitude  of the hormonal response.  On the  basis  of the 
results it was postulated that hormone-receptor interaction  can be considered 
a two-step process: (a) The binding or attachment of hormone to receptor site 
through ionic, hydrogen, and hydrophobic bonds and (b) a disulfide interchange 
reaction  between hormonal  disulfide  and  receptor sulfhydryl.  The  latter step 
is considered to be the reaction which initiates the chain of events leading to the 
observed change  in  permeability. 
Although the distinction between the affinity and intrinsic  activity of a  drug 
for its receptor site has received theoretical  consideration  and  application  in 
pharmacology  (1),  little  usefulness has  been found for these  concepts in  the 
study of hormone-receptor  interactions.  However,  because of the recent  de- 
velopments  in  the  isolation,  characterization,  and  synthesis  of polypeptide 
hormones,  they  may  become  of practical  value  in  the  study  of hormone- 
receptor interactions.  The classic work of du Vigneaud and his colleagues on 
the  neurohypophyseal  hormone  (2-7)  has  evoked  new  and  exciting  pos- 
sibilities  in  the  study  of the  correlation  between  structure  and  activity  of 
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polypeptide hormones.  A  great deal of effort has  already been expended in 
the preparation and biological testing of synthetic analogs of these hormones 
(2-14).  In general these studies have been confined to an investigation of the 
comparative  activities  of a  new analog  in  a  number  of different biological 
test systems. From work of this kind it has been possible  to conclude that a 
particular amino acid in a  given position is more important for one type of 
biological  activity than for  another.  However,  there  have  been few studies 
concerning the effect of a  given structural change upon the affinity and in- 
trinsic  activity of the  hormone for  a  single receptor site.  Undoubtedly this 
can be  attributed  in  part  to  the fact that  a  number of the biological assay 
methods for  these  hormones  employ intact  organisms  and  as  such  are  un- 
suitable  (14). However, in recent years several in vitro assay systems have been 
developed which should  be  suitable  (14).  Obviously  to  be  most  useful the 
response  of  the  given  tissue  should  be  specific,  reproducible,  and  readily 
quantitated.  Perhaps of all the isolated systems which respond to these hor- 
mones, the amphibian urinary bladder most nearly approaches the ideal for a 
system amenable to this type of analysis. From the work of Leaf (15), Bentley 
(16), Sawyer (17), and Schwartz et al.  (18), it is apparent that these hormones 
produce  two  characteristic  responses  in  this  tissue  and  that  relatively few 
other agents mimic these responses. Of the two responses the most reproducible 
and more easily quantitated is the change in bulk flow of water produced when 
the two surfaces of the bladder are exposed to solutions of different total solute 
concentrations.  This  response  has  been  employed by  a  number  of investi- 
eators.  It has the advantage of accuracy, simplicity, and, if certain conditions 
~re  controlled,  of reproducibility.  It  was  selected  therefore  as  particularly 
suitable for a  study of the effect of alterations in hormone structure upon the 
affinity and intrinsic activity of the hormone molecule. 
In considering the interaction of a  hormone molecule with its receptor it is 
axiomatic that some type of chemical interaction must occur. The five natural 
neurohypophyseal  hormones  (oxytocin,  arginine  and  lysine  vasopressin, 
isotocin, and arginine vasotocin) all possess three striking structural features: 
(a)  a  20-membered ring closed by a  disulfide bond;  (b)  charged groups con- 
sisting of an amino group on the amino acid in position 1, a phenolic hydroxyl 
on the amino acid side chain in position 2,  and in all but oxytocin and iso- 
tocin, a  basic group on the amino acid in position 8; and  (c) a  hydrophobic 
or non-polar region in position  3,  4,  and  5.  In a  previous study  (18),  these 
hormones  were  labeled  with  tritium  and  then  employed to  determine  the 
nature  of binding  between  hormone  and  receptor.  In  brief,  evidence  was 
found for the formation of a  covalent chemical bond which was  considered 
to be  disulfide in  nature. 
Granting that such a  bond is actually formed, it could function in one of 
two ways: either to attach the hormone to receptor or to initiate hormonal RASMUSSEN et al.  Structure  and Hormone-Receptor  Interaction  II7  3 
action.  Thus one could envision two possible sequences of the chemical events 
involved in hormone-receptor  interaction.  On the one hand,  the initial  fixa- 
tion  of hormone  to receptor could be brought  about by linkages  other  than 
disulfide  bonds,  specifically  ionic,  hydrogen,  and  hydrophobic  bonds;  and 
the  initiation  of hormone  action  then  induced  by disulfide  bond formation. 
On  the  other  hand,  disulfide  bond formation  might  account  only for initial 
fixation  with  some  other  type of chemical  interaction  being  responsible  for 
the initiation of hormone action.  Obviously, a given change in hormone struc- 
ture might effect one or the other of these two steps, but it might  be possible 
on  the  basis  of a  quantitative  analysis  of hormone-receptor  interaction  to 
decide  between the  two alternatives. 
It is the purpose of this report to describe the results of a  study on the re- 
sponse of the isolated amphibian  urinary bladder to thirty-four different nat- 
ural  and  synthetic  neurohypophyseal  analogs,  and  to  changes  in  hydrogen 
ion concentration. 
Theoretical Considerations 
Before  discussing  the  experimental  techniques,  the  theoretical  foundations 
upon which this study was initiated  will be summarized. 
One current model of hormone  action is that the interaction  of a  hormone 
(h)  with its receptor  (R)  leads  to the formation  of a  complex  (Rh)  which in 
turn  initiates  a  chain  of reactions  leading  to  the  observable physiologic  ac- 
tivity  (ap). 
kl 
h-t- R  ~  Rh  + ap 
k~ 
It must be assumed that the response is some function of the concentration of 
the  hormone-receptor  complex  and  furthermore  that  the  concentration  of 
this  complex  is  the  rate-limiting  factor  in  the  sequence  of reactions  from 
hormone-receptor  interaction  to  physiological  response.  This  latter  is  un- 
doubtedly true for small concentrations  of hormone  but it is not yet possible 
to  prove  its  validity  at  high  hormone  levels.  In  addition  the  assumption  is 
made  that  the receptors represent  a  homogeneous  population. 
With  these few assumptions  the  situation  is  analogous  to  that  of enzyme- 
substrate interaction  or drug-receptor interaction  where 
R  =  free receptor concentration 
r  =  total receptor concentration 
Rh  =  concentration of complex 
h  --  concentration of hormone 
kl  ---  rate of association of R and h 
k2 =  rate of dissociation of Rh *'74  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  46  •  ,965 
Kh-- 
/(H  = 
proportionality  constant  defined  by  ap 
physiological activity,  that  is,  the  measured response 
maximal physiological activity 
k2 
kl 
1  and is a measure of the affinity of the particular analog for the receptor. 
Then it can be shown that 
and  Ap  =  a  r  so that 
o+)(h) 
ap  --  k2  k-+ h 
ap  -  Kh 
(h--5 + 
(1) 
an  expression  analogous  to  the  Michaelis-Menten  expression  for  enzyme- 
substrate  interaction.  In  this  particular  formulation  the  hormone-receptor 
complex is not considered  as  breaking  down into an  active  complex,  but if 
(Rh)  did  break  down  then  the  situation  would  be  completely analogous  to 
the  enzyme-substrate  interaction  and  a  would  be  replaced  by  ks.  In  either 
case the type of response curve would be similar, but in the latter case a  con- 
tinuous supply of hormone would be required. 
In a  study in which there is a  wide range of affinities for the receptor site, 
it is most useful to plot the  log-dose hormone concentration against physio- 
logical response.  The log expression of equation  (1)  rearranged  gives: 
ap 
log (h)  --  log Kh +  log Ap  --  ap  (2) 
which is an expression of the usual log-dose response  (Fig.  1). 
Comparison  of  the  response  of two  hormone  analogs  should  aid  in  dis- 
tinguishing between a  change in  affinity or intrinsic  activity produced by a 
given structural  alteration.  Affinity is indicated by the reciprocal  of Kh,  KR, 
which is a  measure of how much hormone-receptor complex will be formed 
for a  given analog at a  given concentration; and intrinsic activity is indicated 
by  a  which signifies the  effectiveness of a  given concentration  of hormone- 
receptor  complex,  and  thus  determines  the  maximal  physiological  activity 
(Ap)  obtainable  with  a  given  hormonal  analog.  The  effects  expected  from 
structurally induced changes in affinity or intrinsic activity are illustrated in RASMUSSEN et al.  Structure  and Hormone-Receptor Interaction  xt75 
Fig. 1. A change in affinity  shifts the curve along the dose axis without altering 
the maximal obtainable response whereas a  change in intrinsic activity alters 
the maximal response. 
This approach to hormone-receptor interaction can be extended to a  con- 
sideration of competitive and  non-competitive inhibition and  other  special 
circumstances such as the influence of pH change upon hormone action. 
It remains only to point out that a change in affinity implies that the cata- 
lytic function or active center of the hormone molecule has not been influenced 
by the given structural change, whereas a change in intrinsic activity suggests 
an alteration in the active center of catalytic groups of the hormone molecule. 
However, it is  possible  to envision situations in which structural alterations 
not involving the active center could lead to a  decrease of intrinsic activity 
by changing the orientation of the hormone with its receptor site. Hence the 
Affinity  Intrinsic activity 
Log dose 
FIGURE  I.  The left hand  portion of the figure illustrates the hypothetical effect of 
altering the affinity of a hormone for its receptor site without modifying its  intrinsic 
activity. Conversely,  on the right is illustrated the effect of so modifying  hormone struc- 
ture as to alter its intrinsic activity. 
interpretations at  changes in  intrinsic activity are  open  to  more  ambiguity 
than are those in affinity. 
MATERIALS  AND  METHODS 
The urinary bladders obtained from toads, Bufo marinus, weighing 120 to 290 gm were 
employed for  assessing hormonal activity by the  technique of Bentley (16),  with 
only minor modifications. The toad bladder was mounted, serosal side out, in 20 ml 
of amphibian Ringer's (220 mOsM/liter) and contained 3 ml of hypotonic Ringer's 
(50  mOsM/liter). Weight loss was measured every 20  minutes. At the end of each 
20 minute period the inside and outside solutions were changed. For the study of the 
various hormonal analogs the pH was maintained at 7.4. For each dosage level of each 
analog, six separate half-bladders were used.  Observations with the same doses of 
hormone were repeated with a second batch of bladders. After two 90 minute control 
periods,  the appropriate dose of analog was added to the serosal bath. Weight loss 
was measured for three more 90 minute periods.  The rates of weight loss (milligrams 
per minute) for the second and third 20 minute periods were recorded, and the mean 
of the twenty-four  values obtained (two values from each of  twelve half-bladders). The 
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low response values, and  12 to  15 per cent at high response values. The mean values 
for different dosages of each analog were used to plot the log-dose response. To nor- 
malize the  values obtained  on different  bladders  at different times of the  year, the 
response of a given set of bladders to a standard preparation of oxytocin was used. The 
maximal response of various bladder  set~ to oxytocin varied from 32 to 38 mg/min. 
under the conditions of these experiments. The value of 35 mg/min, was chosen as the 
standard and all data normalized to this value in order to have a  more precise com- 
parison of the response of analogs tested at widely different times. The concentration 
required to produce  a  half-maximal effect (/fh)  was used to compare  the  effective- 
ness of the various analogs. 
In the case in which the bladders did not respond to large doses of analog, oxytocin 
was added  at the end  of the  second or third experimental period,  and the response 
followed for an additional one or two periods to determine whether the inactive analog 
had any inhibitory effect. 
The  effect of changes  in  hydrogen  ion  concentration  upon  the  response  of the 
bladder to a  large range of concentrations of oxytocin was studied employing Ringer 
bicarbonate buffers containing  112  ~  Na  +,  4.2 ~  K +,  2  m~ Ca  ++, 2.2 mM phos- 
phate,  and  118  In~ C1- plus HCO3-;  02-5  per cent  CO2 was employed as the  gas 
phase.  The pH of a  particular  buffer was produced  by varying the ratio of C1- to 
HCOa- without  changing  their  total  concentration.  A  dose-response curve  for  the 
hormone at pH's 6.2, 6.4, 6.65, 6.9, 7.2, 7.45, 7.8, and 8.0 was determined in a manner 
similar to that employed in the study of each analog. As an additional means of com- 
paring  responsiveness  as  a  function  of pH,  paired  half-bladders  were  run  at  two 
different pH's in each experiment, and in some experiments the response of the same 
bladders at two different pH's was determined. The response of a given set of bladders 
at  pH  7.45  was  employed  as  the  standard  and  these  responses  normalized.  The 
responses of bladders  studied at  other pFI values were  corrected  to  this  normalized 
value. These particular studies were carried out before those with the various analogs 
and were done on bladders obtained from smaller toads (120 to  150 gm as compared 
to 200 to 250 gm). Only 2 ml of hypotonic Ringer's was added to the bladder rather 
than 3  ml as in the analog studies. Thus in these experiments the maximal response 
was 21  to  27  rag/rain,  rather than  39 to 38 mg/min,  as was the case in the  analog 
studies. 
In  addition  to  this  complete study of the  dose response  as  a  function  of pH for 
oxytocin, a  less extensive study of the effect of variations in hydrogen ion concentra- 
tion upon the response of the bladder to a single concentration of the desamino analog 
of oxytocin was performed. 
To determine the effect of reduction of the hormonal disulfide bond upon hormonal 
activity,  10-~ ~t cysteine was added to the bath 20 minutes before a  standard  dose of 
oxytocin.  The  effects of  10  -2 M glycine  and  10  --2 M oxidized  glutathione  were  also 
studied in the same manner.  The effect of 10  -2 M cysteine upon  the action of cyclic 
AMP  1 (3',5'-adenine mononucleotide)  and theophyUine was also determined. 
A  number of other hormones which  mimic the  action of neurohypophyseal hor- 
1Abbreviatiom,  cyclic  AMP,  3',5'-adenine  mononucleotide;  AVT,  argininc  vasotocin;  LVP, 
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mones upon certain receptor tissues,  such as the uterus or small blood vessels, were 
tested for their effect on the bladder. These were angiotensin, serotonin, epinephrine, 
insulin,  acetylcholine,  bradykinin,  glucagon,  and  parathyroid  hormone. 
The natural  and synthetic analogs were obtained from several sources.  Professor 
Vincent du Vigneaud of Cornell University supplied us with synthetic arginine vaso- 
tocin,  lysine  vasotocin, the ring  amide of oxytocin, sarcosine oxytocin, 2-phenylala- 
nine oxytocin, desamino  oxytocin, desamino-desoxy-oxytocin, 2-O-methyl oxytocin, 
desamino lysine vasopressin,  1-(hemi-d-cystine)-oxytocin, and  1-(hemi-homocystine)- 
oxytocin.  Natural  arginine  vasotocin,  oxytocin,  arginine  vasopressin,  and  lysine 
vasopressin were prepared in our laboratories. Dr. R. Boissonnas  and Dr, H. Schwarz 
of Sandoz  Inc.  supplied  synthetic  oxytocin,  synthetic  lysine  vasopressin,  synthetic 
arginine  vasopressin,  2-phenylalanine  lysine  vasopressin,  3-phenylalanine  oxytocin, 
8-isoleucine oxytocin, 3-valine oxytocin, isotocin, 4-asparagine oxytocin, and brady- 
kinin.  2-Serine  lysine  vasopressin  and  the  tyrosine  homologs  of lysine  vasopressin 
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were obtained from Professor Beyerman of Delft and N. V. Organon of Oss, Holland. 
Professor Joseph Rudinger  of the  Czechoslovak Academy of Science prepared  the 
3-1eucine-  ,  3-alloisoleucine-  ,  3-norleucine-  ,  3-valine-  , 1-(hemi-d-cystine)-, 3-nor- 
valine- ,  1-N methyl- ,  2-0-methyl- , 2-1eucine-  ,  1-N-sarcosyl-  ,  1-N-leucyl-glycyl- 
glycyl-  and  1-N-glycyl  oxytocin.  Dr.  Joseph  Freid  of  E.  R.  Squibb  and  Sons 
donated  the  8-citrulline  oxytocin and  8-citrulline  vasopressin.  Angiotensin  II  was 
supplied by Dr. F. Merlin Bumpus, and serotonin by Dr. D. W. Woolley. 
RESULTS 
The usual weight loss during the control periods was 0.5 to  1.0 mg/min.,  and 
the maximal  response of individual  bladders ranged  from 30 to 40 mg/min. 
Between  these  extremes  there  was  a  linear  relationship  between  the  log- 
dose of active analog and the response. The log-dose responses for five different 
analogs  are  shown in  Fig.  9.  It is  apparent  that  the response obtained with 
the different analogs differed only with respect to the dose required to obtain 
a  given level of response. All the active analogs gave a comparable qualitative 
response indicating  that  none  of the structural  alterations  produced a  loss of 
intrinsic  activity but influenced only the affinity of a  particular  analog for the 
receptor.  The  effectiveness  of the  various  analogs  is  compared  in  Table  I II78  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  4 6  •  i963 
TABLE  I 
RELATIONSHIP  BETWEEN  CHEMICAL  STRUCTURE  AND 
BIOLOGIC  ACTIVITY  OF  ANALOGS  OF  ARGININE  VASOTOCIN 
UPON  THE  AMPHIBIAN  URINARY  BLADDER 
I  "1 
Cy-S -- Tyr -- Ileu -- GIu(NH2)  -- Asp(NH~) -- CyS -- Pro -- Arg -- GIy(NHs) 
1  2  3  4  5  6  7  8  9 
Concentration 
for half-max- 
imal effect 
Preparation  Substitution  (10s M)  K H  AVT* 
pGr r.~nt 
Arginine vasotocin~  None  0.04  2.5  X  109  100 
Lysine vasotocin  8-1ys  0.16  6.2  X  l0 s  25 
8-Isoleucine oxytocin  8-ileu  0.50  2  X  108  8 
8-Citrulline oxytocin  8-citr  0.60  1.7  X  108  6.6 
Oxytocin  8-1eu  1.00  1  X  108  4.0 
4-Asparagine oxytocin  4-asp(NH2),  8-1eu  1.00  1  X  l0 s  4.0 
Sarcosine oxytocin  8-1eu, 9-sar  1.60  6.3  X  107  2.5 
Isotocin  4-set, 8-ileu  2.50  4  X  107  1.6 
Arginine vasopressin  3-phe  3.15  3.2  X  107  1.3 
Desamino oxytocin  (-I, NH~), 8-1eu  8.80  1.1  X  107  0.45 
Lysine vasopressin  3-phe, 8-1ys  10.00  1  X  107  0.40 
3-Alloisoleucine oxytocin  3-alloileu, 8-1eu  12.00  8.3  X  106  0.34 
Oxytocin ring amide  6-NI-I2 (-7, 8, 9)  14.00  7.2  X  10 e  0.28 
3-Leucine oxytocin  3-1eu, 8-1eu  17.00  6  X  106  0.24 
8-Citrulline vasopressin  3-phe, 8-citr  25.00  4  X  106  0.16 
3-Valine oxytocin§  3-val, 8-1eu  33.50  3  X  106  0.12 
2-Phenylalanine oxytocin  2-phe, 8-1eu  41.60  2.4  X  106  0.098 
2-O-Methyl oxytocinl[  2-O-Me, 8-1eu  47.00  2.1  X  106  0.085 
3-Norvaline oxytocin  3-norval, 8-1eu  83.00  1.2  X  10  e  0.048 
Desamino lysine vasopres-  (-1, NH2), 3-phe, 8-  118.00  8.5  X  105  0.036 
sin¶  lys 
l-N-Methyl oxytocin  1-N-Me, 8-1eu  121.00  8.3  X  l0 s  0.083 
Desamino-desoxy-oxytocin  (-1, NH~), 2-phe, 8-  200.00  5  X  105  0.020 
leu 
1-(hemi-d-cystine) oxyto-  1-d-cysteine, 8-1eu  237.00  4.2  X  105  0.017 
cinll 
1- (hemi-d-cystine) oxyto- 
cin** 
l-(hemi-homocystine) oxy- 
tocin 
l-d-cysteine, 8-1eu  250.00  4  X  105  0.016 
1-homocysteine, 8-  270.00  3.6  X  105  0.015 
leu 
* KB is the reciprocal of the concentration of hormone needed to produce a  half-maximal re- 
sponse and is a  measure of the affinity.  Per cent AVT refers to the potency of the particular 
analog  in  reference  to  that  of  arginine  vasotocin. 
Synthetic and natuFal preparations of arginine vasotocin, arginine vasopressin,  lysine vaso- 
prcssin,  and  oxytocin gave comparable  activities. 
§ Samples of this analog obtained from Sandoz, Inc., and from Professor Rudinger had similar 
potencies. 
II Obtained from Professor Rudinger. 
¶  Relative estimate because of insufficient material to do a  complete  analysis. 
** Obtained from Professor du Vigneaud. 
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T  A  B  L  E  I---Concluded 
Concentration 
for haLf-max- 
imal effect 
Preparation  Substitution  (i0  "~ M)  KH  ACT* 
3-Norleucine oxytodn  3-norleu, 8-1eu  307.00  3.2  X  105  0.013 
3-Phenylalanine  oxytocin  3-phe, 8-1eu  315.00  3.1  X  105  0.012 
2-Phenylalanine  lysine  2-phe, 3-phe, 8-1ys  500.00  2  X  l0  s  0.0080 
vasopressin 
l-N-Glycyl oxytocin  1-N-gly, 8-1eu  968.00  1  X  10  ~  0.0043 
1-N-Sarcosyl oxytocin  1-N-sat, 8-1eu  1,000.00  1  X  10  s  0.0040 
la-Tyrosine lysine vaso-  la-tyr, 3-phe, 8-1ys  1,000.00  I  X  106  0.0040 
pressin~:~ 
l-N-Leu-cylglycylglycyl  oxy-  l-N-(leu-gly-gly),  8-  1,380.00  7.2  X  104  0.0031 
tocin  leu 
2-Leucine oxytocin  2-1eu, 8-1eu  5,440.00  1.8  X  104  0.00074 
2-Serine lysine vasopressin  2-ser, 3-phe, 8-1ys  --  --  Inactive 
where  (K~)  for each analog is recorded. The potency of the analog is com- 
pared to that of arginine vasotocin  (AVT).  All but one of the analogs pos- 
sessed biological activity. The inactive analog was 2-serine  lysine vasopressin 
which had  neither direct  nor  inhibitory activity at  the  highest dose  tested 
(5  ×  10  -5 M).  Its lack of activity may have been due to the lack of sufficient 
material to test at higher doses. 
One  other  analog,  2-0-methyl oxytocin  prepared  by  du  Vigneaud,  was 
found on repeated testing to exhibit an unusual activity.  It was inactive at 
low doses, gave a  small effect at moderate doses  (I  ×  10  -7 M) but no effect 
at  higher doses.  The  higher doses  did not act  as  an  inhibitor of oxytocin. 
However, the same analog prepared by Rudinger and coworkers did possess 
full activity at high dosage. There is at present no explanation for this differ- 
ence. 
A  number of substances besides oxytocin have an '¢oxytocic" effect upon 
the isolated uterus. Some of these were tested for their effect upon the isolated 
bladder.  As  seen in Table  II,  angiotensin II,  which on a  weight basis  has 
one-eigth of the oxytocic activity of oxytocin on the rat uterus  (19),  had no 
effect on  the  isolated bladder  even  at  a  dose  2,500  times that  of oxytocin 
{Table  I)  required  to  produce a  half-maximal effect.  Similarly,  serotonin, 
bradykinin,  epinephrine,  acetylcholine,  and  insulin  had  no  action  on  the 
bladder  (Table  If)  whereas theophylline and 3',5'  cyclic AMP did possess 
activity, as previously demonstrated by Orloff and Handler  (20). 
The results shown in Fig. 2 indicate that in all likelihood the various analogs 
are acting in a  similar manner upon the same receptor sites. To test this sup- 
position further,  the effects of submaximal and just  maximal doses of two 
different analogs were studied. The results with the submaximal doses were 
additive,  and  the response with just maximal doses of two analogs was no 
greater than with either alone. IISO  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  46  •  1963 
The effect of alteration of the disulfide bond upon hormonal activity was 
determined by adding  10  -~ M cysteine  (pH  7.4)  to the serosal bath.  Under 
these circumstances, a  dose of either oxytocin, lysine vasopressin, valyl oxy- 
tocin, or desamino oxytocin, five times greater than that sufficient to produce 
a  maximal  response  under  normal  conditions,  caused  no  change  in  per- 
meability (Table III). Furthermore, if cysteine were added after the hormone 
began to exert its action, the hormonal effect was reversed immediately, the 
bladder returning to its original state of relative impermeability. This effect 
TABLE  II 
EFFECT  OF  NON-NEUROHYPOPHYSEAL  AGENTS  UPON  THE 
PERMEABILITY  OF  THE  AMPHIBIAN  URINARY  BLADDER 
Preparation  Concentration  i01 M  Response 
mg/mln. 
Angiotensin  II  2.5  0 
Insulin  100.0  0 
Parathyroid  hormone  50.0  0 
Glucagon  10.0  0 
Bradykinin  10.0  0 
Serotonin  100.0  0 
Epinephrine  100.0  0 
Acetylcholine  100.0  0 
Theophylline  1,000.0  15.2 
Caffeine  l, 000.0  14.7 
3',5'-AMP  400.0  18.2 
TABLE  III 
THE  EFFECT  OF  CYSTEINE  AND  GLYCINE 
l0  -~  M  UPON  THE  RESPONSE  OF  THE  AMPHIBIAN  URINARY 
BLADDER  TO  VARIOUS  AGENTS 
Rate of weight 
Agent  Concentration  Glycine  10-2 M  Cysteine  10t ~  loss 
mg/min. 
Oxytocin  1  X  I0  -s  M  --  --  22 
Oxytoein  1  X  10-sM  -}-  --  19 
Oxytocin  5  X  10  -s  ~t  --  +  1.3 
Cyclic  AMP  5  X  10  -3 ~  --  --  16 
Cyclic  AMP  5  X  10  -8 M  +  --  13 
Cyclic  AMP  5  X  10  -3 M  --  +  15 
Theophylline  5  X  10  -s  ~  --  --  23 
Theophylline  5  X  10  -~  M  +  --  26 
Theophylline  5  X  10  -s ~  --  +  21 
None  --  --  --  1.5 
None  --  +  --  0.9 
None  --  --  +  1.2 RASMtrSS~N et al.  Structure  and Hormone-Receptor  Interaction  II8x 
of cysteine was completely reversible.  When  the  cysteine was washed  out of 
the  serosal  bath,  the  bladder  would  then  respond  normally  to  hormone. 
Glycine  and  oxidized  glutathione  at  the  same  concentrations  had  no  effect 
upon hormonal  action.  Both 5  ×  10  -8 M 3' ,5'  cyclic AMP and  5  ×  10  -2 M 
theophylline  (which  mimic  hormone  action)  induced  a  characteristic  per- 
meability  change  in  the  presence  of  10  -3 M cysteine  (Table  III)  indicating 
that  the  cysteine had  not inhibited  cellular  processes responsible for change 
in membrane permeability. 
4O 
c 
E 
~  2o 
0 
e- 
•  -~  I0 
I  I 
I  2  5  4  5 
Log  dose 
FIOLrP.E 3.  The  effect of 5  X  10  -3  M cysteine 
upon  the  log-dose response  to  two  different 
analogs:  8-citrulline  oxytocin and  lysine vaso- 
pressin.  The  closed circles (O)  and  the  closed 
triangles  (A)  show the  log-dose response  to 
citrulline  oxytocin and  lysine vasopressln,  re- 
spectively, in  the  absence of cysteine,  and  the 
open  circles (o)  and  open  triangles (Ix) in  its 
presence. 
The effect of 5  ×  10  -3 M cysteine upon the log-dose response to two different 
analogs  with  different  affinities,  lysine vasopressin  and  8-citrulline  oxytocin, 
was studied.  The results are shown in Fig.  3.  This dose of cysteine shifted the 
log-dose response of each analog to a  comparable degree along the dose axis. 
These findings do not exclude the disulfide bridge as the active center because 
they may be explained in terms of the equilibrium conditions of the reaction 
between the  hormone  analog  and  cysteine.  In  fact,  these  findings  are  to  be 
expected  if it  is  assumed  (a)  that  the  equilibrium  constant  of the  reaction 
between hormone  (analog) and receptor is the same in the presence or absence 
of cysteine,  (b) that  only hormone molecules in the disulfide form are active, 
(c) that reaction of cysteine with hormone reaches equilibrium rapidly under 
these  conditions,  and  (d)  that  the  concentration  of  disulfide-containing 
(native)  analog is an inverse function of the cysteine concentration.  In other 
words if in  the  case  of either  analog,  there  are  two competing  reactions  in 
the presence of cysteine: 
~i  /SSR' 
R  +  -SR'  ~  R%S  - 
Hormone  Receptor 
and 
R  -SR*  ~  R%S  - 
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At these low concentrations of hormone there would not appear  to be  sig- 
nificant further sulfhydryl-disulfide interchange reactions between hormone 
and hormone-cysteine complexes. 
The rate of weight loss  vs.  concentration of oxytocin as a  function of pH 
is plotted in Fig. 4.  It is apparent that there is a  decreased response with in- 
creasing hydrogen ion concentration, and the most striking effect is upon the 
maximal obtainable response. This is more clearly shown in Fig. 5 where the 
pH 
25  1  ~  ,  7.8  ,  7.45 
7.2 
~  6.9 
6.65 
~  5  6.4  g: 
I  5  I0  15 
[h]xlo 
Fxoul~.s 4.  The rate of weight loss vs. oxytocin concentration as a function of pH. At 
pH 6.4, 6.65, and 6.9 the response was also measured at higher hormone concentrations 
to ensure that the maximal response was obtained. These data are not plotted in this 
figure, nor are the results obtained at pH 8.0 which were nearly identical to those at 
pH 7.8. 
log of the maximal physiological activity (zip) is plotted as a  function of pH. 
From the data recorded in Fig. 4  the negative log of hormone concentration 
(ph) was plotted against the rate of weight loss; and from this plot,  the ap- 
parent pKh at each pH determined graphically. The pKh was plotted as a func- 
tion of pH as was the log of the response (a~) produced by a small dose  (1  X 
I0  -s M)  of hormone  (Fig.  5).  It was apparent  that there are  two ionizable 
groups of importance in determining the bladder response to hormone. Ap- 
plying the rules worked out for enzyrne-substrate interactions (2 I), the group 
with the apparent pK of 7.75  is either on the free hormone or free receptor 
whereas the one with an apparent pK of 7.1 is either on the hormone-receptor 2.0 
log ap 
1.0 
0.0 
8.0 
7.8 
PKh 
7.6 
7.4 
7.2 
1.5 
log Ap 
1.0 
0.5 
I 
I 
I 
! 
loo 
pK=7.75 
Is 
I  I  I  I  I  ! 
pK=7,1 
I 
I 
I°  t 
I  I  I  I  I 
6.4  68  7.2  7.6  8.0 
pH 
FmuP~  5.  A  plot  of  log  ap,  pKh, 
and  log ,4p  as  a  function of pH for 
the  response  of  the  bladder  to 
oxytocin. 
Log  ap 
0 
6.0 
pK  =7.6 
/ 
/ 
/ 
I  |  I  I 
6.4.  6.8  7.2  7.6  8.0 
pH 
Fxotrfu~ 6.  A  plot of log ap vs.  pH for 8  X  10  --s ~  desamino oxytocin. Compare with 
the upper portion of Fig. 5. 
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complex or is involved at some subsequent step in the sequence of reactions 
leading to the physiologic response. 
The only group on the free hormone which could have an apparent pK of 
7.75  is the a-amino group although the ionization constant for this group is 
usually somewhat lower.  It  seems  unlikely that  this  is  the  group  involved 
because it is not essential for the activity of the hormone  (Table  I)  and be- 
cause a  plot of the log of the physiological response  (ap) against pH for the 
desamino analog is  nearly identical  (Fig.  6) with that for oxytocin  (Fig.  5). 
This indicates that the group is a  part of the free receptor. 
DISCUSSION 
This  work extends  the  observations  of Sawyer  (17)  and Jard,  Maetz,  and 
Morel  (22) who have studied the relative potencies of some of these analogs 
upon the isolated frog bladder.  There are slight differences in some of their 
relative values as compared to ours, but no major discrepancy except for the 
activity of lysine vasotocin.  The explanation for our observation of a  much 
higher activity for this  analog than that of Jard et al. may be the fact that 
different  species  of amphibia  were  employed  and/or  that  the  samples  of 
lysine  vasotocin were prepared  in  different laboratories  and  may not  have 
been comparable. All data on comparative biological activities recorded here 
and elsewhere must be considered only relative because all these agents are 
unstable  in  solution  or  as  dry powder.  For  instance,  we  have  noted  unex- 
plained losses of activity of some analogs tollowing lyophilization or storage. 
Because of these difficulties, the data on the biological activities of these agents 
obtained  at  different times with different hormone preparations in different 
laboratories cannot be compared in a  strict sense. 
From the data in Table  I  it is possible to determine the effect of substitu- 
tions in various positions upon hormonal affinity. 
Changes in  Position  1  Removal of the  a-amino  group  gives an  analog 
with  10  per cent of original affinity; methylation of a-amino group,  0.8 per 
cent; substitution  of D-cysteine or homocysteine for L-cysteine, 0.4 per cent; 
additional  peptide  bond  on  a-amino group,  0.01  per  cent or  less;  increase 
size ot ring by addition of tyrosine between position  1 and 2,  1 per cent. 
Changes in Position 2  Removal of hydroxyl group, 2.2 per cent of original 
affinity; methylation of hydroxyl group,  1.7  per cent; change  from phenyl- 
alanine to leucine, 0.56  per cent. 
Changes in Position 3  Isoleucine to alloisoleucine, 6.2 per cent of original 
affinity; to leucine, 5.7 per cent; to valine, 2.2 per cent; to phenylalanine, 2.0 
per cent; to norvaline,  1.0 per cent and to norleucine, 0.25 per cent. RASMUSSEN et al.  Structure  and Hormone-Receptor Interaction  xi8  5 
Changes in  Position  4  Glutamine to  asparagine,  no change in  affinity; 
glutamine to serine, at least 40 per cent of the original affinity. 
Changes in Position  6  Amide for tripeptide side chain, 0.28 per cent of 
original affinity. 
Changes in Position  8  Arginine to lysine, 25 per cent of original affinity; 
to isoleucine, 8.0 per cent; to citrulline, 6.6 per cent; to leucine, 4 per cent. 
Changes in Position 9  Glycine to sarcosine, 62 per cent ot original affinity. 
Although these findings indicate the profound effect which relatively small 
structural changes produce upon the affinity of neurohypophyseal hormones 
for this tissue, it is important to recognize that an extremely high degree of 
chemical purity of each analog is required if the results are to be meaningful. 
For example, if the  1-(hemi-d-cystine)-oxytocin were contaminated with as 
little  as  0.4 per cent of oxytocin then the results  obtained could be due to 
contamination with this material rather than due to the intrinsic biological 
activity of the  (D)  isomer. This degree of contamination lies beyond the re- 
solving power of most of our present day separation techniques, therefore the 
results obtained with the less  active analogs must be considered only as the 
best approximation to the true activity which is currently possible. 
The present data  (Tables  I-III; Figs.  2 and 3)  suggest a  number of con- 
clusions concerning the structural requirements for hormonal activity on this 
amphibian membrane.  (a)  The integrity of the disulfide bond appears to be 
essential for the intrinsic activity of the hormone molecule. The fact that a 
dose of 10  -~ M cysteine is required to prevent hormonal action is of interest 
because,  if the postulated receptor sulfhydryl group  actually exists,  then it 
has a  reactivity toward the hormonal disulfide at least  106 times greater than 
the sulfhydryl of free cysteine.  (b) The size of the disulfide closed ring is not 
critical  because  both  hemi-homocysteine oxytocin  and  la-tyrosine  lysine 
vasopressin had full intrinsic activity.  (c) None of the charged groups on the 
vasotocin  molecule  appears  essential;  the  desamino,  and  2-phenylalanine 
analogs were  active,  as  was  the ring amide containing neither proline nor 
arginine. Nor is the character of the non-polar group in position 3 or 4 critical. 
No analogs with substitutions in position 5 were available for study. Although 
it is possible to remove the tyrosyl hydroxyl group in position 2 and still pre- 
serve intrinsic activity, the substitution of serine for an aromatic amino acid 
in that position resulted in an inactive analog at least at the dose tested. How- 
ever,  2-1eucine oxytocin had full intrinsic activity despite its extremely low 
affinity tor  the  receptor  site.  Thus,  the  prime  requirements  for  hormonal 
activity appear to be a  20- to 23-membered ring closed by a  disulfide bridge. 
The aromatic ring and phenolic hydroxyl in position 2  are  very important 
in  enhancing the  affinity of hormone for  its  receptor site.  Further  work is i186  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  4 6  •  I963 
required to establish whether yet larger or smaller ring structures may possess 
activity. 
It should be noted that the tripeptide side chain, the a-amino nitrogen in 
position  1,  and tyrosyl hydroxyl group in position 2 are not essential for in- 
trinsic  activity  although  they  greatly enhance  the  affinity of hormone for 
receptor site.  In fact, the data suggest that a  high degree of molecular com- 
plementarity is required between hormone and receptor site in order to retain 
a  high degree of hormone-receptor site affinity. Any change, even the rela- 
tively minor one of substituting  lysine for arginine in position 8  or alloiso- 
leucine for isoleucine in position 3 results in significant loss of affinity. The 
latter  observations  also  indicate  the  important  role  that  steric  factors  un- 
doubtedly play in the low affinity of a number of the analogs for the receptor 
site. 
The analysis of the effect of hydrogen ion concentration upon hormonal 
response (Figs. 4-6) indicates that it may be possible to obtain useful informa- 
tion about hormone-receptor interactions by an analysis similar to that em- 
ployed in  the  study  of enzyme-substrate  interactions  (21).  The  data  must 
certainly be interpreted with caution. However, they indicate that there is an 
ionizable group on the receptor which is important in determining the mag- 
nitude of the hormonal response. Clearly they do not unequivocally establish 
the nature of this group,  but are consistent with the previous proposal that 
the interaction between hormone and bladder involves an SH group on the 
receptor and the hormonal disulfide bond  (18,  23),  and would predict that 
little  tritium-labeled hormone would be  bound at  pH  6.4,  a  previously es- 
tablished fact (18). 
Other peptides (e.g.,  angiotensin) not possessing disulfide bonds are inactive 
in  this  system,  but  do  possess  oxytocic activity in  other  tissues  (e.g.  myo- 
metrium)  (14).  The most likely explanation for this difference is that angio- 
tensin and oxytocin interact with different uterine receptor sites  to initiate 
myometrial contraction. 
The S-S  bond may be necessary for oxytocin action on the toad  bladder 
but not on the uterus, the nature of the chemical interaction between hormone 
and receptor sites in these two different tissues being fundamentally different. 
In this regard, it is noteworthy that the 2,0-methyl oxytocin has been shown 
by Berankova, Rychik, Jost,  Rudinger, and Sorm  (24)  to be a  competitive 
inhibitor of oxytocin on the rat uterus and that 2-1eucine oxytocin (25)  has a 
diminished intrinsic activity in this  same system.  These  same  two  analogs, 
prepared  in  the  same  laboratory,  had  no  such  effect  upon  the  amphibian 
bladder.  In fact,  both  possessed  full intrinsic activity at  appropriate  doses. 
These data suggest that there is an essential difference in  the nature of the 
chemical interactions responsible for the initiation of hormone action in these 
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oxygen of the tyrosine moiety might interfere with the proper orientation of 
the disulfide bond and thereby prevent its interaction with a  specific group 
on the receptor site. A  difference in receptor site topography might then ex- 
plain the fact that the same analog can possess full intrinsic activity in one 
tissue and serve as a  competitive inhibitor in another. This striking difference 
between the response of the amphibian bladder  and  the  uterus to  analogs 
modified in the 2  position certainly deserves further critical study, particu- 
larly because the natural hormones for these two tissues (AVT and oxytocin) 
possess the same ring structure. If hormones and receptor sites possess a  high 
degree of molecular complementarity, it might be expected that the structure 
of the region of the receptor site complementary to the region of the hormone 
molecule around the tyrosine in position 2 would be quite similar.  If such is 
the case,  then the data suggest that  the catalytic step in hormone-receptor 
interaction is different in the two tissues. There remains, of course, the alter- 
native possibility that  the alteration of the hormone molecule in position 8 
(outside the ring)  sufficiently alters the topography of the molecule around 
position 2 so that the complementarity at the receptor sites is different in the 
different tissues. In the latter case, the catalytic step could be  the same  and 
the difference in tissue response be due to alterations in orientation of hormone 
analog to receptor site. The work of Martin and Schild (26) also suggests that 
the nature of the catalytic event in hormone receptor interaction differs in 
different  tissues  for  the  structurally  related  neurohypophyseal  hormones. 
They  found  that  thiols  prevented  the  effect  of these  hormones  upon  the 
myometrium but not upon vascular  smooth muscle. 
It is  of interest  that  insulin,  even  at  high concentration, was  ineffective 
even  though it  possesses a  20-membered ring similar  to  that  found in  the 
neurohypophyseal  hormones.  In  contrast  oxytocin  and  vasopressin  have 
been found to mimic certain effects of insulin (27,  28).  Also some of the ac- 
tions of insulin can be inhibited and others mimicked by sulfhydryl-blocking 
reagents (29,  30), all of which points to the possibility that one or more of the 
disulfide bonds of the insulin molecule may be of functional importance. The 
lack of insulin effect upon the bladder would not seem compatible with this 
thesis.  However,  it is  quite possible and  even likely that its  molecular size 
and shape  are  such that  its disulfide bond cannot be oriented in  a  proper 
manner with reactive  groups  on  the  bladder  receptor  site.  Large  doses  of 
insulin do not inhibit the response of the bladder to oxytocin suggesting that 
the  affinity of insulin for  the bladder  receptor sites  is  of an  extremely low 
order. 
In  contrast  to  the  high  degree  of specificity that  the  neurohypophyseal 
hormones and insulin possess for their natural receptor sites, they all have a 
rather  similar degree of reactivity with membrane components involved in 
mitochondrial swelling  (31).  Furthermore, other non-hormonal agents  pos- ~i88  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  46  •  x963 
sessing either  sulfhydryl or  disulfide bonds cause  a  similar response in  the 
mitochondrial system but cannot mimic the natural effects of these hormones 
(23).  In view of these differences and because of the subtle differences in the 
response of two natural receptors to the same synthetic analog, it seems un- 
likely that the mitochondrial system will be helpful in defining the sequence 
of events in the action of these hormones upon their specific target  tissues. 
Although the differences in the behavior of the specific tissue receptor sites 
and  the  mitochondrial sites  suggest  that  the  general  significance  and  the 
nature  of the  chemical interactions are  different,  the mitochondrial effects 
are of interest per se. 
The present data  and that previously reported  (18,  23)  are all consistent 
with  the  following  hypothesis.  The  interaction  of  hormone  with  bladder 
receptor site can be considered a  two-step process consisting of (a)  the multi- 
point  attachment of hormone to  receptor  by  ionic,  hydrogen,  and  hydro- 
phobic bonds,  and short range forces; and  (b)  the interaction of a  receptor 
sulfhydryl group with  the  hormonal disulfide  bond.  Changes  in  hormonal 
structure,  other  than  disruption of the  disulfide  bond,  influence  primarily 
the  affinity  of hormone  for  receptor  site  (step  1).  The  disulfide-sulfhydryl 
interchange  (step  2)  appears  to  be  responsible  for  initiating  the  chain  of 
events leading to the observed physiological effect.  There  are  a  number of 
possible ways in which this latter reaction might induce the tissue response. 
It could, as previously suggested (18)  initiate directly a  structural alteration 
in the mucosal membrane of the bladder by triggering a  wave of disulfide- 
sulfhydryl  interchanges.  However,  if  the  vasopressin-like  actions  of cyclic 
AMP  and  theophylline  (20)  on  bladder  permeability are  not  adventitious 
pharmacologic  phenomena,  this  simplest  of  models  is  no  longer  tenable. 
In any case, it seems likely that there are multiple events between hormone- 
receptor interaction and the final change in permeability. Only further study 
can establish the nature of these events, but the role of cyclic AMP certainly 
deserves critical attention. 
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